|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.2 USD | -3.23% |
|
+3.45% | +35.39% |
| 05-07 | Top Premarket Gainers | MT |
| 05-06 | Transcript : FibroGen, Inc., Q1 2024 Earnings Call, May 06, 2024 |
FibroGen, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 55.9 million compared to USD 36.16 million a year ago. Net loss was USD 32.93 million compared to USD 76.71 million a year ago.
Basic loss per share from continuing operations was USD 0.33 compared to USD 0.81 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +35.39% | 119M | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B | |
| -6.26% | 11.42B |
FIBROGEN, INC. 
